NCT07023731 2026-02-19A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D MutationArvinas Inc.Phase 1/2 Recruiting159 enrolled
NCT05253053 2025-06-12To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid TumorsTransThera Sciences (Nanjing), Inc.Phase 1/2 Completed84 enrolled
NCT04913337 2024-10-02Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor MalignanciesNGM Biopharmaceuticals, IncPhase 1/2 Active not recruiting179 enrolled
NCT04742959 2024-04-26Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid TumorsTransThera Sciences (Nanjing), Inc.Phase 1/2 Completed203 enrolled
NCT03665285 2024-03-08A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid TumorsNextCure, Inc.Phase 1/2 Completed109 enrolled 25 charts
NCT03602079 2023-08-03Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GeneKlus Pharma Inc.Phase 1/2 Completed49 enrolled